Breaking News Instant updates and real-time market news.

AXP

American Express

$79.71

0.2 (0.25%)

, MAT

Mattel

$26.10

0.43 (1.68%)

04:55
02/20/17
02/20
04:55
02/20/17
04:55

Toy Industry Association to hold fair

International Toy Fair 2017 is being held in New York on February 17-21.

AXP

American Express

$79.71

0.2 (0.25%)

MAT

Mattel

$26.10

0.43 (1.68%)

HAS

Hasbro

$98.50

0.86 (0.88%)

COST

Costco

$175.86

0.11 (0.06%)

AMZN

Amazon.com

$845.07

0.93 (0.11%)

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 28

    Feb

  • 19

    Mar

  • 28

    Mar

AXP American Express
$79.71

0.2 (0.25%)

01/20/17
NOMU
01/20/17
NO CHANGE
Target $63
NOMU
Reduce
Nomura troubled by American Express earnings miss
Excluding restructuring charges and the benefit of a lower tax rate, American Express reported core earnings per share of 83c, below the consensus of 99c, Nomura analyst Bill Carcache tells investors in a research note. The miss is troubling since the company raised its Q4 outlook at the end of last quarter against a low bar, Carcache writes. He believes the launch of Chase's Sapphire Reserve is likely bringing unexpected headwinds. The analyst keeps a Reduce rating on American Express with a $63 price target.
01/30/17
01/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) and Madison Square Garden (MSG) were upgraded to Overweight from Equal Weight at Morgan Stanley. 2. Dick's Sporting (DKS) upgraded to Buy from Neutral at Goldman with analyst Stephen Tanal saying he believes Dick's is well positioned in a post The Sports Authority world and will reap the rewards of consolidation through sales and earnings growth driven by share gains and improved product allocations from key vendors. Further, Dick's is transitioning to a fully in-sourced eCommerce operation, which should drive improved profitability. 3. American Express (AXP) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Sanjay Sakhrani citing improved fundamentals and visibility. "The low end of the company's 2017 earnings guidance is 'very achievable' just through stated operating cost reductions and capital management, and any revenue growth represents upside potential," Sakhrani tells investors in a research note. He raised his price target for American Express shares to $91 from $81. 4. Royal Caribbean (RCL) upgraded to Buy from Hold at Argus with analyst John Staszak says the company has "few competitors and strong market opportunities." He expects it to benefit from lower costs and increased international demand going forward. 5. Movado (MOV) upgraded to Buy from Neutral at Sidoti with analyst Frank Camma saying recent retail weakness is reflected in price and tariff concerns are overblown. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/17
KBWI
01/30/17
UPGRADE
Target $91
KBWI
Outperform
American Express upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Sanjay Sakhrani upgraded American Express to Outperform citing improved fundamentals and visibility. The low end of the company's 2017 earnings guidance is "very achievable" just through stated operating cost reductions and capital management, and any revenue growth represents upside potential, Sakhrani tells investors in a research note. He raised his price target for American Express shares to $91 from $81.
01/20/17
SPHN
01/20/17
NO CHANGE
Target $70
SPHN
Underweight
American Express guidance a negative read to Discover, says Stephens
Stephens analyst Vincent Caintic reiterates an Underweight rating for American Express (AXP) after disappointing 2017 EPS guidance and believes the company's Q4 results are a negative read for Discover (DFS). The analyst says that American Express' results lead him to reconsider upside for Discover's Q4 results, nothing that the latter is under more rewards and loan growth pressure relative to the former. Caintic also raised his price target for American Express' shares to $70 from $65 on valuation.
MAT Mattel
$26.10

0.43 (1.68%)

02/08/17
PIPR
02/08/17
NO CHANGE
PIPR
Piper discusses resurfacing of Hasbro, Mattel deal speculation
Piper Jaffray analyst Stephanie Wissink points out that over her firm's 15 years of coverage, speculation of a merger between Hasbro (HAS) and Mattel (MAT) has surfaced several times. Hasbro's strong Q4 earnings report and share rally, in contrast with Mattel's negative Q4 preannouncement and pullback, has reignited the conjecture, Wissink tells investors in a research note. Economically a merger would create value, but a combination of the number two and three toy companies "would require significant evaluation from anti-trust authorities," the analyst writes. She believes a deal is possible if the Federal Trade Commission widens the boundaries around "youth entertainment & play," say to include video games, digital games and media. Hasbro closed yesterday up 67c to $94.98 while Mattel, after rallying in early trading, closed down 4c to $25.88. Wissink adds that she can find upwards of $500M of merger synergies if the two companies were to combine.
01/30/17
UBSW
01/30/17
NO CHANGE
Target $32
UBSW
Buy
Mattel price target lowered to $32 from $36 at UBS
UBS analyst Arpine Kocharyan lowered her price target on Mattel to $32 from $36. The analyst said there is no demand issue with core brands, inventories are cleaner, and Cars 3 and Wonder Woman are visible catalysts ahead. However, near-term margins will be lower and the company cannot cost-save its way to recovery. Kocharyan reiterated her Buy rating on Mattel shares.
02/13/17
GSCO
02/13/17
INITIATION
Target $27
GSCO
Neutral
Mattel initiated with a Neutral at Goldman
Goldman analyst Michael Ng initiated Mattel with a Neutral and a $27 price target. The analyst said Mattel is undergoing a turnaround in several of its core brands but consensus estimates are already looking for a meaningful recovery, creating increased risk.
02/13/17
02/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Air Products (APD) reinstated with an Overweight at Barclays. 2. Hasbro (HAS) was initiated with a Buy at Goldman, while Mattel (MAT) was initiated with a Neutral. 3. Jagged Peak Energy (JAG) initiated with a Positive at Susquehanna. 4. Kimbell Royalty Partners (KRP) initiated with a Buy at Wunderlich. 5. HollyFrontier (HFC) reinstated with a Sell at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
HAS Hasbro
$98.50

0.86 (0.88%)

01/26/17
01/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) downgraded to Market Perform from Outperform at Wells Fargo with analyst Larry Biegelsen saying the company's "disappointing" 2017 revenue guidance suggests its pharma business is facing more headwinds than he expected. J&J guided to underlying sales growth in 2017 of 3.0%-3.5%, which is a "sharp deceleration" from 7.4% underlying growth in 2016, Biegelsen tells investors in a research note. Biegelsen downgraded Johnson & Johnson before the company's announced acquisition of Actelion (ALIOF). He wrote, though, that any deal wouldn't likely close until late 2017. 2. United Technologies (UTX) downgraded to Hold from Buy at Argus with analyst John Eade citing valuation. 3. Ethan Allen (ETH) downgraded to Neutral from Buy at Dougherty with analyst Jeremy Hamblin changing his views given a lack of visibility on the timing and impact on sales catalysts, including Disney Collection launch and US State Department contract, fewer new product introductions, tough second half of 2017 comps, and significant downside risk to consensus fiscal 2017 and fiscal 2018 estimates. 4. Hasbro (HAS) downgraded to Neutral from Buy at Monness Crespi. 5. Mattel (MAT) downgraded to Neutral from Buy at MKM Partners with analyst Eric Handler saying the turnaround story has lost momentum as a slower than expected retail environment, fewer product reorders, and increased promotional activity resulted in disappointing year-end results. Handler expects foreign exchange headwinds, rising input costs, and an unfavorable product mix to continue into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/17
GSCO
02/13/17
INITIATION
Target $110
GSCO
Buy
Hasbro initiated with a Buy at Goldman
Goldman analyst Michael Ng initiated Hasbro with a $110 price target saying he sees upside to consensus estimates on higher revenue, while its portfolio of entertainment-backed toys provides earnings visibility. Ng said boys toys will have an unprecedented amount of movie support, momentum in Disney Princess should drive growth in Girls, and balance sheet strength creates optionality.
COST Costco
$175.86

0.11 (0.06%)

01/20/17
01/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN) initiated with a Buy at Aegis. 2. Alphabet (GOOG, GOOGL) and Facebook (FB) were resumed with an Overweight at Pacific Crest, while Twitter (TWTR) was resumed with a Sector Weight. 3. Costco (COST) coverage was resumed with a Buy at Stifel, while Wal-Mart (WMT) and Target (TGT) were resumed with a Hold. 4. Whole Foods (WFM) was initiated with a Market Perform, while Sprouts Farmers Markets (SFM) was initiated with an Outperform at William Blair. 5. CBS (CBS) was reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/17
BERN
02/07/17
INITIATION
BERN
Market Perform
Costco initiated with a Market Perform at Bernstein
Bernstein analyst Brandon Fletcher expects Costco to continue to generate "slow growth," and the analyst says that the stock is near its "valuation ceiling." Target $170.
02/07/17
02/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Target (TGT) and Dollar General (DG) were initiated with an Outperform at Bernstein, while Lowe's (LOW) was initiated with an Underperform. The firm also initiated Costco (COST), Home Depot (HD), and Wal-Mart (WMT) with a Market Perform. 2. Aetna (AET) and UnitedHealth (UNH) were assumed with an Overweight at Cantor. 3. Philips (PHG) initiated with a Hold at Berenberg. 4. Costamare (CMRE) initiated with a Neutral at Citi. 5. BioMarin (BMRN) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/10/17
SUSQ
02/10/17
INITIATION
Target $195
SUSQ
Positive
Costco initiated with a Positive at Susquehanna
Target $195.
AMZN Amazon.com
$845.07

0.93 (0.11%)

02/15/17
RBCM
02/15/17
NO CHANGE
RBCM
LogMeln weakness overdone, says RBC Capital
After LogMeIn (LOGM) fell 9% following the launch of Amazon's (AMZN) online meeting offering, Chime, RBC Capital analyst Matthew Hedberg says that Chime "appears to be competitive" with LogMeIn's join.me. However, the analyst says that it will take time for Chime to fully catch up with LogMeIn's features and ease of use. He keeps a $125 price target and an Outperform rating on LogMeIn.
02/15/17
OPCO
02/15/17
NO CHANGE
Target $970
OPCO
Outperform
Amazon.com price target raised to $970 from $900 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Amazon.com to $970 from $900 after cloud returns prove to be much higher than his firm's cloud analyst Tim Horan had originally expected, which should offset near-term concerns on retail investments. The analyst believes CAPX will ramp in the near-term, as Amazon Web Services' utilization in new availability zones increases, and expects lower marginal returns in the longer term given increasing competition/pricing pressure. He reiterates an Outperform rating on the shares.
02/17/17
PIPR
02/17/17
INITIATION
Target $8
PIPR
Neutral
J.C. Penney assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst Erinn Murphy assumed coverage of J.C. Penney (JCP) with a Neutral rating and $8 price target. The analyst worries about the underlying secular pressure Amazon.com (AMZN) is putting on the industry.
02/17/17
02/17/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Buy at Citi by analyst Peter Christiansen, who said the company has the capability of "redefining" brick-and-mortar payments and commerce enablement. 2. Aerie Pharmaceuticals (AERI) initiated by Roth Capital analyst Sa'ar Yaniv with a Buy rating and $69 price target as he expects Rhopressa and Roclatan approval in 2018 and 2019. 3. Aegis analyst Chris Kapsch initiated Albemarle (ALB) with a Buy and a $108 price target, calling it a "must-own" stock over at least the next couple years. 4. Arch Coal (ARCH) initiated with a Buy at Jefferies by analyst Christopher LaFemina, citing the company's portfolio of "low-cost" U.S. coal assets and a "clean" balance sheet. 5. Piper Jaffray analyst Erinn Murphy assumed coverage of Nordstrom (JWN) with a Neutral rating and $41 price target, saying she believes price transparency may continue to hinder the company's results. Murphy also assumed coverage of J.C. Penney (JCP) with a Neutral rating and $8 price target, noting worries about the underlying secular pressure Amazon.com (AMZN) is putting on the industry, and assumed coverage of Kohl's (KSS) with a Neutral rating and $40 price target, as she believes earnings growth will be tough amid the current environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

BA

Boeing

$337.73

-2.43 (-0.71%)

08:50
01/20/18
01/20
08:50
01/20/18
08:50
Periodicals
Boeing not a sell just yet, Barron's says »

Boeing stock has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, EADSY

Airbus

$28.43

0.755 (2.73%)

08:24
01/20/18
01/20
08:24
01/20/18
08:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$178.46

-0.8 (-0.45%)

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$337.73

-2.43 (-0.71%)

VZ

Verizon

$51.91

0.36 (0.70%)

NYT

New York Times

$21.90

1.7 (8.42%)

TWX

Time Warner

$93.36

0.39 (0.42%)

DIS

Disney

$110.59

0.17 (0.15%)

TIME

Time Inc.

$18.55

0.05 (0.27%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

BAC

Bank of America

$31.72

0.24 (0.76%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BK

BNY Mellon

$56.61

1.26 (2.28%)

WLKP

Westlake Chemical Partners

$24.45

-0.1 (-0.41%)

MON

Monsanto

$120.66

1.8 (1.51%)

DLTR

Dollar Tree

$114.73

1.83 (1.62%)

CE

Celanese

$112.96

1.93 (1.74%)

LYB

LyondellBasell

$119.92

3.03 (2.59%)

TSE

Trinseo

$79.45

2.2 (2.85%)

EYE

National Vision

$43.13

1.12 (2.67%)

ETFC

E-Trade

$54.28

0.63 (1.17%)

LPLA

LPL Financial

$59.03

0.53 (0.91%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

SCHW

Charles Schwab

$55.48

0.15 (0.27%)

ADS

Alliance Data

$261.82

5.88 (2.30%)

FISV

Fiserv

$138.11

0.17 (0.12%)

FLT

FleetCor

$206.65

3.4 (1.67%)

HAWK

Blackhawk

$45.25

0.1 (0.22%)

MTZ

MasTec

$53.30

1.25 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

  • 18

    Mar

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.